» Articles » PMID: 25984990

Emerging Concepts Promising New Horizons for Marine Biodiscovery and Synthetic Biology

Overview
Journal Mar Drugs
Publisher MDPI
Specialties Biology
Pharmacology
Date 2015 May 19
PMID 25984990
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

The vast oceans of the world, which comprise a huge variety of unique ecosystems, are emerging as a rich and relatively untapped source of novel bioactive compounds with invaluable biotechnological and pharmaceutical potential. Evidence accumulated over the last decade has revealed that the diversity of marine microorganisms is enormous with many thousands of bacterial species detected that were previously unknown. Associated with this diversity is the production of diverse repertoires of bioactive compounds ranging from peptides and enzymes to more complex secondary metabolites that have significant bioactivity and thus the potential to be exploited for innovative biotechnology. Here we review the discovery and functional potential of marine bioactive peptides such as lantibiotics, nanoantibiotics and peptidomimetics, which have received particular attention in recent years in light of their broad spectrum of bioactivity. The significance of marine peptides in cell-to-cell communication and how this may be exploited in the discovery of novel bioactivity is also explored. Finally, with the recent advances in bioinformatics and synthetic biology, it is becoming clear that the integration of these disciplines with genetic and biochemical characterization of the novel marine peptides, offers the most potential in the development of the next generation of societal solutions.

Citing Articles

Comparative Transcriptomics to Identify RNA Writers and Erasers in Microalgae.

Ambrosino L, Riccardi A, Welling M, Lauritano C Int J Mol Sci. 2024; 25(15).

PMID: 39125576 PMC: 11312118. DOI: 10.3390/ijms25158005.


Functional Genomics of a Collection of Gammaproteobacteria Isolated from Antarctica.

Giovannini M, Vieri W, Bosi E, Riccardi C, Lo Giudice A, Fani R Mar Drugs. 2024; 22(6).

PMID: 38921549 PMC: 11205219. DOI: 10.3390/md22060238.


Identification and expression of MarCE, a marine carboxylesterase with synthetic ester-degrading activity.

Carr C, Gottsch F, Francesco Rodrigues de Oliveira B, Murcia P, Jackson S, Wei R Microb Biotechnol. 2024; 17(6):e14479.

PMID: 38881500 PMC: 11180994. DOI: 10.1111/1751-7915.14479.


Health-Promoting Effects of Bioactive Compounds from Plant Endophytic Fungi.

Wijesekara T, Xu B J Fungi (Basel). 2023; 9(10).

PMID: 37888253 PMC: 10608072. DOI: 10.3390/jof9100997.


Nortopsentins as Leads from Marine Organisms for Anticancer and Anti-Inflammatory Agent Development.

Pecoraro C, Terrana F, Panzeca G, Parrino B, Cascioferro S, Diana P Molecules. 2023; 28(18).

PMID: 37764226 PMC: 10537790. DOI: 10.3390/molecules28186450.


References
1.
Cleveland J, Montville T, Nes I, Chikindas M . Bacteriocins: safe, natural antimicrobials for food preservation. Int J Food Microbiol. 2002; 71(1):1-20. DOI: 10.1016/s0168-1605(01)00560-8. View

2.
Brogden K, Guthmiller J, Taylor C . Human polymicrobial infections. Lancet. 2005; 365(9455):253-5. PMC: 7119324. DOI: 10.1016/S0140-6736(05)17745-9. View

3.
Thenmozhi R, Nithyanand P, Rathna J, Pandian S . Antibiofilm activity of coral-associated bacteria against different clinical M serotypes of Streptococcus pyogenes. FEMS Immunol Med Microbiol. 2009; 57(3):284-94. DOI: 10.1111/j.1574-695X.2009.00613.x. View

4.
Balaban N, Giacometti A, Cirioni O, Gov Y, Ghiselli R, Mocchegiani F . Use of the quorum-sensing inhibitor RNAIII-inhibiting peptide to prevent biofilm formation in vivo by drug-resistant Staphylococcus epidermidis. J Infect Dis. 2003; 187(4):625-30. DOI: 10.1086/345879. View

5.
Sushko Y, Novotarskyi S, Korner R, Vogt J, Abdelaziz A, Tetko I . Prediction-driven matched molecular pairs to interpret QSARs and aid the molecular optimization process. J Cheminform. 2014; 6(1):48. PMC: 4272757. DOI: 10.1186/s13321-014-0048-0. View